Pasukhas Group Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Pasukhas Group Berhad şirketinin toplam hissedar öz sermayesi MYR135.6M ve toplam borcu MYR11.9M olup, bu da borç-öz sermaye oranını 8.8% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla MYR182.6M ve MYR47.0M dir.

Anahtar bilgiler

8.8%

Borç/özkaynak oranı

RM 11.94m

Borç

Faiz karşılama oranı	n/a
Nakit	RM 11.52m
Eşitlik	RM 135.63m
Toplam yükümlülükler	RM 47.02m
Toplam varlıklar	RM 182.65m

Son finansal sağlık güncellemeleri

Recent updates

Does Pasukhas Group Berhad (KLSE:PASUKGB) Have A Healthy Balance Sheet?

Nov 18

Not Many Are Piling Into Pasukhas Group Berhad (KLSE:PASUKGB) Just Yet

Sep 26

A Piece Of The Puzzle Missing From Pasukhas Group Berhad's (KLSE:PASUKGB) 26% Share Price Climb

Feb 18

Sentiment Still Eluding Pasukhas Group Berhad (KLSE:PASUKGB)

Dec 28

Here's What's Concerning About Pasukhas Group Berhad's (KLSE:PASUKGB) Returns On Capital

Aug 08

Investors Still Aren't Entirely Convinced By Pasukhas Group Berhad's (KLSE:PASUKGB) Revenues Despite 43% Price Jump

Apr 19

Investors Will Want Pasukhas Group Berhad's (KLSE:PASUKGB) Growth In ROCE To Persist

Mar 23

Is Pasukhas Group Berhad (KLSE:PASUKGB) Using Debt In A Risky Way?

Jul 14

Would Pasukhas Group Berhad (KLSE:PASUKGB) Be Better Off With Less Debt?

Mar 31

A Look At Pasukhas Group Berhad's (KLSE:PASUKGB) CEO Remuneration

Dec 01

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: PASUKGB 'nin kısa vadeli varlıkları ( MYR139.9M ) kısa vadeli yükümlülüklerini ( MYR38.2M ) aşıyor.

Uzun Vadeli Yükümlülükler: PASUKGB şirketinin kısa vadeli varlıkları ( MYR139.9M ) uzun vadeli yükümlülüklerini ( MYR8.8M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: PASUKGB 'nin net borç/öz sermaye oranı ( 0.3% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: PASUKGB 'nin borç/öz sermaye oranı son 5 yılda 55.1% seviyesinden 8.8% seviyesine düştü.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: PASUKGB şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: PASUKGB un, serbest nakit akışı her yıl % 15.2 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Pasukhas Group Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Does Pasukhas Group Berhad (KLSE:PASUKGB) Have A Healthy Balance Sheet?

Is Pasukhas Group Berhad (KLSE:PASUKGB) Using Debt In A Risky Way?

Would Pasukhas Group Berhad (KLSE:PASUKGB) Be Better Off With Less Debt?

Recent updates

First quarter 2025 earnings released: EPS: RM0 (vs RM0.051 loss in 1Q 2024)

New minor risk - Share price stability

Does Pasukhas Group Berhad (KLSE:PASUKGB) Have A Healthy Balance Sheet?

Pasukhas Group Berhad, Annual General Meeting, Nov 28, 2024

Not Many Are Piling Into Pasukhas Group Berhad (KLSE:PASUKGB) Just Yet

Pasukhas Group Berhad Appoints Chin Hoong Lim as Chief Financial Officer

New major risk - Revenue and earnings growth

New minor risk - Financial data availability

A Piece Of The Puzzle Missing From Pasukhas Group Berhad's (KLSE:PASUKGB) 26% Share Price Climb

New major risk - Share price stability

Pasukhas Group Berhad Appoints Adeline Tang Koon Ling as Company Secretary

Sentiment Still Eluding Pasukhas Group Berhad (KLSE:PASUKGB)

Pasukhas Group Berhad Announces Resignation of Lim Ee Vone as Chief Financial Officer

Pasukhas Group Berhad Announces Resignation of Lim Ee Vone as Chief Financial Officer

Pasukhas Group Berhad Announces the Retirement of Wan Thean Hoe as Executive Director

Pasukhas Group Berhad, Annual General Meeting, Nov 29, 2023

Insufficient new directors

New major risk - Financial data availability

Here's What's Concerning About Pasukhas Group Berhad's (KLSE:PASUKGB) Returns On Capital

High number of new directors

First quarter 2023 earnings released: RM0.002 loss per share (vs RM0.032 loss in 1Q 2022)

Investors Still Aren't Entirely Convinced By Pasukhas Group Berhad's (KLSE:PASUKGB) Revenues Despite 43% Price Jump

Investors Will Want Pasukhas Group Berhad's (KLSE:PASUKGB) Growth In ROCE To Persist

Pasukhas Group Berhad Announces Cessation of Yap Chee Keong as Independent and Non Executive Member of Risk Committee

Third quarter 2022 earnings released: RM0.004 loss per share (vs RM0.003 loss in 3Q 2021)

Pasukhas Group Berhad Announces Resignation of Tan Tong Lang as Company Secretary

Pasukhas Group Berhad Appoints Wong Yuet Chyn as Company Secretary

Second quarter 2022 earnings released: RM0.003 loss per share (vs RM0.001 profit in 2Q 2021)

First quarter 2022 earnings released: RM0.003 loss per share (vs RM0.002 profit in 1Q 2021)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Second quarter 2021 earnings released: EPS RM0.001 (vs RM0.02 loss in 2Q 2020)

Director Siew Mak has joined 5th company board

Is Pasukhas Group Berhad (KLSE:PASUKGB) Using Debt In A Risky Way?

Company Secretary has left the company

Would Pasukhas Group Berhad (KLSE:PASUKGB) Be Better Off With Less Debt?

Full year 2020 earnings released: RM0.045 loss per share (vs RM0.013 loss in FY 2019)

Pasukhas Group Berhad has completed a Follow-on Equity Offering in the amount of MYR 17.119821 million.

A Look At Pasukhas Group Berhad's (KLSE:PASUKGB) CEO Remuneration

Third quarter 2020 earnings released: RM0.003 loss per share

Pasukhas Group Berhad Appoints Dato' Nik Ismail Bin Dato' Nik Yusoff as Independent and Non Executive Member of Audit Committee

Pasukhas Group Berhad Announces Resignation of Chan Man Chung as Non Independent and Non Executive Director

Pasukhas Group Berhad has completed a Follow-on Equity Offering in the amount of MYR 8.168532 million.

First half earnings released

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin